122 related articles for article (PubMed ID: 37482548)
1. MR imaging characteristics of different pathologic subtypes of esophageal carcinoma.
Wang Z; Chu F; Bai B; Lu S; Zhang H; Jia Z; Zhao K; Zhang Y; Zheng Y; Xia Q; Li X; Kamel IR; Li H; Qu J
Eur Radiol; 2023 Dec; 33(12):9233-9243. PubMed ID: 37482548
[TBL] [Abstract][Full Text] [Related]
2. A prospective analysis of the diagnostic accuracy of 3 T MRI, CT and endoscopic ultrasound for preoperative T staging of potentially resectable esophageal cancer.
Guo J; Wang Z; Qin J; Zhang H; Liu W; Zhao Y; Lu Y; Yan X; Zhang Z; Zhang T; Zhang S; Dominik NM; Kamel IR; Li H; Qu J
Cancer Imaging; 2020 Sep; 20(1):64. PubMed ID: 32912319
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer T-staging on MRI: A preliminary study using cine and static MR sequences.
Haefliger L; Jreige M; Du Pasquier C; Ledoux JB; Wagner D; Mantziari S; Shäfer M; Vietti Violi N; Dromain C
Eur J Radiol; 2023 Sep; 166():111001. PubMed ID: 37516096
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of 3-T MRI for Preoperative T Staging of Esophageal Cancer After Neoadjuvant Chemotherapy, With Histopathologic Correlation.
Wang Z; Guo J; Qin J; Zhang H; Zhao Y; Lu Y; Yan X; Zhang F; Zhang Z; Zhang T; Zhang S; Dong Y; Jiang L; Grimm R; Li H; Kamel IR; Qu J
AJR Am J Roentgenol; 2019 Apr; 212(4):788-795. PubMed ID: 30673335
[TBL] [Abstract][Full Text] [Related]
5. [A comparison between 3.0 T MRI and histopathology for preoperative T staging of potentially resectable esophageal cancer].
Wang ZQ; Zhang FG; Guo J; Zhang HK; Qin JJ; Zhao Y; Ding ZD; Zhang ZX; Zhang JB; Yuan JH; Li HL; Qu JR
Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(11):843-846. PubMed ID: 28355740
[No Abstract] [Full Text] [Related]
6. Comparison between free-breathing radial VIBE on 3-T MRI and endoscopic ultrasound for preoperative T staging of resectable oesophageal cancer, with histopathological correlation.
Qu J; Zhang H; Wang Z; Zhang F; Liu H; Ding Z; Li Y; Ma J; Zhang Z; Zhang S; Dong Y; Jiang L; Zhang W; Grimm R; Kiefer B; Kamel IR; Qin J; Li H
Eur Radiol; 2018 Feb; 28(2):780-787. PubMed ID: 28799124
[TBL] [Abstract][Full Text] [Related]
7. MRI features in differentiating mucosal high-grade neoplasia from early invasive squamous cell cancer of the esophagus.
Qu J; Wang Z; Qin J; Zhang H; Zhao Y; Lu Y; Yan X; Zhang S; Wang S; Kamel IR; Li H
Eur Radiol; 2020 Jun; 30(6):3455-3461. PubMed ID: 32086576
[TBL] [Abstract][Full Text] [Related]
8. [Exploration of the classification of gross tumor volume and pathological staging of esophageal carcinoma].
Xu Q; Zhu SC; Liu ZK; Cao YK; Song CL; Li YM; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):432-5. PubMed ID: 20819484
[TBL] [Abstract][Full Text] [Related]
9. Esophageal carcinoma: Ex vivo evaluation by high-spatial-resolution T
Wei Y; Wu S; Gao F; Sun T; Zheng D; Ning P; Zhao C; Li Z; Li X; Li L; Zhu S
J Magn Reson Imaging; 2017 Jun; 45(6):1609-1616. PubMed ID: 27711986
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.
Crabtree TD; Kosinski AS; Puri V; Burfeind W; Bharat A; Patterson GA; Hofstetter W; Meyers BF
Ann Thorac Surg; 2013 Aug; 96(2):382-90. PubMed ID: 23731608
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of MRI for Esophageal Carcinoma: A Systematic Review and Meta-Analysis.
Lee SL; Yadav P; Starekova J; Christensen L; Chandereng T; Chappell R; Reeder SB; Bassetti MF
Radiology; 2021 Jun; 299(3):583-594. PubMed ID: 33787334
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
13. Staging of esophageal carcinoma in vitro with 4.7-T MR imaging.
Yamada I; Murata Y; Izumi Y; Kawano T; Endo M; Kuroiwa T; Shibuya H
Radiology; 1997 Aug; 204(2):521-6. PubMed ID: 9240547
[TBL] [Abstract][Full Text] [Related]
14. [MR-endoscopic US correlation for loco-regional staging of rectal carcinoma].
Anthonioz-Lescop C; Aubé C; Luet D; Lermite E; Burtin P; Ridereau-Zins C
J Radiol; 2007 Dec; 88(12):1865-72. PubMed ID: 18235347
[TBL] [Abstract][Full Text] [Related]
15. Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma.
Vazquez-Sequeiros E; Wang L; Burgart L; Harmsen W; Zinsmeister A; Allen M; Jondal M; Wiersema M
Gastroenterology; 2002 Jun; 122(7):1815-21. PubMed ID: 12055589
[TBL] [Abstract][Full Text] [Related]
16. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.
Fütterer JJ; Engelbrecht MR; Huisman HJ; Jager GJ; Hulsbergen-van De Kaa CA; Witjes JA; Barentsz JO
Radiology; 2005 Nov; 237(2):541-9. PubMed ID: 16244263
[TBL] [Abstract][Full Text] [Related]
17. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT.
Lee G; I H; Kim SJ; Jeong YJ; Kim IJ; Pak K; Park DY; Kim GH
J Nucl Med; 2014 Aug; 55(8):1242-7. PubMed ID: 24868109
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution MRI: a comparison with conventional MRI at 3 tesla.
Yuan Y; Chen L; Ren S; Wang Z; Chen Y; Jin A; Li S; Fang X; Wang T; Bian Y; Yang Q; Bai C; Hao Q; Lu J
Cancer Imaging; 2019 Dec; 19(1):83. PubMed ID: 31801587
[TBL] [Abstract][Full Text] [Related]
19. Esophageal imaging by MR and CT: study of normal anatomy and neoplasms.
Quint LE; Glazer GM; Orringer MB
Radiology; 1985 Sep; 156(3):727-31. PubMed ID: 4023234
[TBL] [Abstract][Full Text] [Related]
20. Comparison Between Size and Stage of Preoperative Tumor Defined by Preoperative Magnetic Resonance Imaging and Postoperative Specimens After Radical Resection of Esophageal Cancer.
Gao Z; Hua B; Ge X; Liu J; Xue L; Zhen F; Luo J
Technol Cancer Res Treat; 2019 Jan; 18():1533033819876263. PubMed ID: 31551000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
